fbpx

Speed is the key
to commercialization
in the IVD market.

KeyTech-Header.jpg)" data-image-id="151131" data-ultimate-bg-style="vcpb-default" data-bg-img-repeat="repeat" data-bg-img-size="cover" data-bg-img-position="" data-parallx_sense="30" data-bg-override="0" data-bg_img_attach="scroll" data-upb-overlay-color="" data-upb-bg-animation="" data-fadeout="" data-bg-animation="left-animation" data-bg-animation-type="h" data-animation-repeat="repeat" data-fadeout-percentage="30" data-parallax-content="" data-parallax-content-sense="30" data-row-effect-mobile-disable="true" data-img-parallax-mobile-disable="true" data-rtl="false" data-custom-vc-row="" data-vc="8.7.2" data-is_old_vc="" data-theme-support="" data-overlay="false" data-overlay-color="" data-overlay-pattern="" data-overlay-pattern-opacity="" data-overlay-pattern-size="" >

At Key Tech, we believe that speed-to-data is a competitive advantage. We’ve worked in IVD consumable and instrument development for over 20 years, and we understand what it takes to create success in the marketplace.

Right now, in-home diagnostics and technologies like genetic sequencing and CRISPR are driving competition like never before. Older technologies are advancing; PCR tests are now faster and more accurate than ever, and antigen tests are becoming more specific. No matter what type of clinical situation, a new IVD platform must be reliable, accurate, and easy to use.

Solving the unsolvable.

Key Tech will ask the tough assay integration and automation questions to help you wade through the unknowns and find the right solution. We take pride in our reputation for proving the feasibility of complex technologies, then translating them to a viable commercial product.

We’ve formalized a framework to look at the whole system and ensure the instrument and consumable serve the assay. (See our Framework for Evaluating Assays for Automation.) By working closely with the client assay team, we are able to prove feasibility and burn down risk by building custom test fixtures that help inform product architecture decisions.

Our engineers and designers have successfully streamlined the process of IVD design and development for a wide range of customers like Thermo Fisher, Bio-Rad and GenMark Diagnostics (now a part of Roche). No matter what type of assay, we’ll help you deliver accurate clinical data with a competitive edge.

Services for In Vitro
Diagnostics Development Groups

Independent
Technical Reviews

Early Concept Exploration –
User-Focused & Technical

De-Risking and
Data Collection

Alpha and Beta
Prototype Development

Test Bed
Development

Relevant Work

1 LiquidHandlers 01

Liquid Handlers

Custom gantry and pipettor design

2 SamplePrep 01

Sample Prep
Instruments

Purification platform

3 Molecular Sample Platform 01

Sample to
Answer Platforms

Genetic and molecular multiplex instruments and consumables

4 PointofCare 01

Point of Care
Instruments

POC hematocrit meter

5 CartridgeArchitecture 01

Cartridge Architecture & Design

Custom cartridge design to serve the assay

6 OnboardReagents 01

Onboard Reagents

Liquid, dried, pelleted, lyophilized

7 SampleCollection 01

Sample Collection

Oral fluid collection device

8 LifeSciences 01

Life Sciences

RUO technology, instruments, and consumables

9 AlgDev 01

Algorithm Development

Image detection, machine vision, precision detection algorithm

10 DetectionTech 01

Detection Technologies

De-risking and integration of optical, ultrasonic, and electrical potential measurements

11 GUI 01

GUI & Workflow Definition

Design for ease of use

12 TestFixture 01

Test Fixtures

Smart test beds for R&D and verification

13 Thermal 01

Thermal Control Management

Heating, interface design, materials, feedback and control

14 Fluidic 01

Fluidic Control

Fluidic motivation of various volumes and types of fluids

15 Derisk 01

Novel Tech De-risking

Digital microfluidics

16 ComplexDurable 01

Complex Durable to Consumable Interface Design

Reliable actuation for various types of connections

Video

How can we help you? Reach Out...